rs13386404
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000091.5(COL4A3):c.828+20A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0462 in 1,603,438 control chromosomes in the GnomAD database, including 5,152 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.12 ( 2264 hom., cov: 32)
Exomes 𝑓: 0.039 ( 2888 hom. )
Consequence
COL4A3
NM_000091.5 intron
NM_000091.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.66
Publications
7 publications found
Genes affected
COL4A3 (HGNC:2204): (collagen type IV alpha 3 chain) Type IV collagen, the major structural component of basement membranes, is a multimeric protein composed of 3 alpha subunits. These subunits are encoded by 6 different genes, alpha 1 through alpha 6, each of which can form a triple helix structure with 2 other subunits to form type IV collagen. This gene encodes alpha 3. In the Goodpasture syndrome, autoantibodies bind to the collagen molecules in the basement membranes of alveoli and glomeruli. The epitopes that elicit these autoantibodies are localized largely to the non-collagenous C-terminal domain of the protein. A specific kinase phosphorylates amino acids in this same C-terminal region and the expression of this kinase is upregulated during pathogenesis. This gene is also linked to an autosomal recessive form of Alport syndrome. The mutations contributing to this syndrome are also located within the exons that encode this C-terminal region. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 2-227254194-A-G is Benign according to our data. Variant chr2-227254194-A-G is described in ClinVar as Benign. ClinVar VariationId is 255007.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.321 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL4A3 | NM_000091.5 | c.828+20A>G | intron_variant | Intron 14 of 51 | ENST00000396578.8 | NP_000082.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL4A3 | ENST00000396578.8 | c.828+20A>G | intron_variant | Intron 14 of 51 | 1 | NM_000091.5 | ENSP00000379823.3 |
Frequencies
GnomAD3 genomes AF: 0.118 AC: 17979AN: 151864Hom.: 2249 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
17979
AN:
151864
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0580 AC: 14441AN: 249070 AF XY: 0.0521 show subpopulations
GnomAD2 exomes
AF:
AC:
14441
AN:
249070
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0387 AC: 56114AN: 1451462Hom.: 2888 Cov.: 29 AF XY: 0.0376 AC XY: 27211AN XY: 722890 show subpopulations
GnomAD4 exome
AF:
AC:
56114
AN:
1451462
Hom.:
Cov.:
29
AF XY:
AC XY:
27211
AN XY:
722890
show subpopulations
African (AFR)
AF:
AC:
10919
AN:
33014
American (AMR)
AF:
AC:
1699
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
AC:
1996
AN:
26026
East Asian (EAS)
AF:
AC:
4090
AN:
39586
South Asian (SAS)
AF:
AC:
3157
AN:
86050
European-Finnish (FIN)
AF:
AC:
2991
AN:
53386
Middle Eastern (MID)
AF:
AC:
406
AN:
5738
European-Non Finnish (NFE)
AF:
AC:
27697
AN:
1102980
Other (OTH)
AF:
AC:
3159
AN:
59994
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
2285
4570
6855
9140
11425
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1246
2492
3738
4984
6230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.119 AC: 18025AN: 151976Hom.: 2264 Cov.: 32 AF XY: 0.118 AC XY: 8729AN XY: 74272 show subpopulations
GnomAD4 genome
AF:
AC:
18025
AN:
151976
Hom.:
Cov.:
32
AF XY:
AC XY:
8729
AN XY:
74272
show subpopulations
African (AFR)
AF:
AC:
13503
AN:
41416
American (AMR)
AF:
AC:
842
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
261
AN:
3470
East Asian (EAS)
AF:
AC:
354
AN:
5176
South Asian (SAS)
AF:
AC:
204
AN:
4826
European-Finnish (FIN)
AF:
AC:
696
AN:
10526
Middle Eastern (MID)
AF:
AC:
15
AN:
292
European-Non Finnish (NFE)
AF:
AC:
1969
AN:
67980
Other (OTH)
AF:
AC:
176
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
692
1384
2077
2769
3461
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
242
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Jun 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Autosomal recessive Alport syndrome Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
Splicevardb
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.